Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Lilly's EBGLYSS Shows Rapid Skin Clearance And Symptom Relief In Phase 3b Study
posted:
Wed, 09/30/2026 - 08:34 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study
posted:
Wed, 09/30/2026 - 01:00 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lilly's Retatrutide Delivered Significant Weight Loss, A1C Reduction In Phase 3 Trial
posted:
Wed, 09/30/2026 - 00:37 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Eli Lilly Might Be the Next Stock I Buy
posted:
Tue, 09/29/2026 - 21:30 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip
posted:
Tue, 09/29/2026 - 21:20 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
posted:
Tue, 09/29/2026 - 18:42 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.
posted:
Tue, 09/29/2026 - 17:50 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lilly: Zepbound Shows Greater Weight Loss Than Wegovy HD In New Analysis
posted:
Tue, 09/29/2026 - 11:31 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lilly's Zepbound Shows Greater Weight Loss Than Wegovy HD In New Analysis
posted:
Tue, 09/29/2026 - 07:44 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lilly's Foundayo Tops Oral Semaglutide In New Diabetes Analysis
posted:
Tue, 09/29/2026 - 04:44 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lilly's Foundayo Outperforms Oral Semaglutide In New Diabetes Analysis
posted:
Tue, 09/29/2026 - 04:00 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?
posted:
Mon, 09/28/2026 - 09:21 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
posted:
Mon, 09/28/2026 - 08:00 EDT
by:
Nasdaq Technology
#channels::
#All
,
#Business
,
#Nasdaq
,
#Technology
,
#NasdaqTechnology
,
#Stocks
Eli Lilly Just Announced Game-Changing News
posted:
Mon, 09/28/2026 - 04:23 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
posted:
Fri, 09/25/2026 - 08:51 EDT
by:
CNBC Business
#channels::
#All
,
#News
,
#Business
,
#CNBCBusiness
,
#CNBC
,
#Stocks
,
#Markets
Pagination
Page 1
Next page
››